Sequent Scien.

53
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE807F01027
  • NSEID: SEQUENT
  • BSEID: 512529
INR
200.25
-7.4 (-3.56%)
BSENSE

Dec 05

BSE+NSE Vol: 14.73 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
1,551.00
1,369.00
1,420.00
1,412.00
1,361.00
1,179.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,551.00
1,369.00
1,420.00
1,412.00
1,361.00
1,179.00
Expenditure (Ex Depriciation)
Stock Adjustments
-18.00
-29.00
18.00
-49.00
-39.00
4.00
Raw Materials Consumed
829.00
789.00
814.00
842.00
733.00
600.00
Power & Fuel Cost
32.00
35.00
42.00
33.00
28.00
24.00
Employee Cost
281.00
250.00
258.00
231.00
187.00
165.00
Operating Expenses
65.00
70.00
81.00
85.00
91.00
76.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
69.00
56.00
57.00
57.00
50.00
45.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
38.00
54.00
53.00
27.00
31.00
29.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,389.00
1,308.00
1,408.00
1,303.00
1,149.00
1,008.00
Operating Profit (PBDIT) excl Other Income
161.00
61.00
11.00
109.00
212.00
170.00
Other Income
14.00
10.00
6.00
10.00
8.00
10.00
Operating Profit (PBDIT)
176.00
72.00
18.00
120.00
220.00
180.00
Interest
60.00
48.00
35.00
15.00
24.00
35.00
Profit before Depriciation and Tax
115.00
24.00
-17.00
104.00
196.00
144.00
Depreciation
66.00
61.00
55.00
51.00
50.00
50.00
Profit Before Taxation & Exceptional Items
49.00
-37.00
-72.00
52.00
145.00
94.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
44.00
-54.00
-137.00
52.00
136.00
94.00
Provision for Tax
12.00
-25.00
-15.00
8.00
32.00
12.00
Profit After Tax
32.00
-29.00
-121.00
44.00
104.00
82.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
95.00
99.00
88.00
59.00
-79.00
-140.00
Profit Available for appropriations
117.00
63.00
-32.00
100.00
16.00
-70.00
Appropriations
117.00
63.00
-32.00
100.00
16.00
-70.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
25.00%
0.00%
Earnings Per Share
0.88
-1.44
-4.88
1.66
3.87
2.87
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 13.26% vs -3.60% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 163.45% vs 413.71% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 26.34% vs 35.39% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 208.94% vs 75.72% in Mar 2024

Compare Profit and Loss Results of Sequent Scien.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,551.00
0
1,551.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
1,551.00
0
1,551.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-18.00
0
-18.00
0%
Raw Materials Consumed
829.00
0
829.00
0%
Power & Fuel Cost
32.00
0
32.00
0%
Employee Cost
281.00
0
281.00
0%
Operating Expenses
65.00
0
65.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
69.00
0
69.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
38.00
0
38.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
1,389.00
0
1,389.00
0%
Operating Profit (PBDIT) excl Other Income
161.00
0.00
161.00
0%
Other Income
14.00
0
14.00
0%
Operating Profit (PBDIT)
176.00
0
176.00
0%
Interest
60.00
0
60.00
0%
Profit before Depriciation and Tax
115.00
0
115.00
0%
Depreciation
66.00
0
66.00
0%
Profit Before Taxation & Exceptional Items
49.00
0
49.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
44.00
0
44.00
0%
Provision for Tax
12.00
0
12.00
0%
Profit After Tax
32.00
0
32.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
95.00
0
95.00
0%
Profit Available for appropriations
117.00
0
117.00
0%
Appropriations
117.00
0
117.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.88
0
0.88
0%
Profit And Loss - Net Sales
Net Sales 1,551.37 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.26% vs -3.60% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 161.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 163.45% vs 413.71% in Mar 2024

Profit And Loss - Interest
Interest 60.75 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.34% vs 35.39% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 32.26 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 208.94% vs 75.72% in Mar 2024